Explore how multiple generic competitors impact drug prices. Learn about the non-linear price drop, the paradox of competition, and the role of PBMs in health economics.
Despite making up 90% of prescriptions, generic drugs face deep-rooted perception issues. Learn how transparency, tech, and better communication are shifting public trust - and why the future isn't about price, but proof.
Evergreening lets pharmaceutical companies extend drug patents with minor tweaks, blocking cheaper generics and keeping prices high. Learn how this legal strategy impacts drug access and what’s being done to stop it.